# Bioavailability of Paracetamol, Amoxicillin and Talinolol Before, Immediately and One Year After Gastric Bypass Operation

> **NCT02514941** · PHASE1 · COMPLETED · sponsor: **University Medicine Greifswald** · enrollment: 12 (actual)

## Conditions studied

- Morbid Obesity

## Interventions

- **DRUG:** paracetamol
- **DRUG:** amoxicillin
- **DRUG:** talinolol
- **PROCEDURE:** gastroduodenoscopy with biopsy
- **PROCEDURE:** gastrojejunoscopy with biopsy
- **PROCEDURE:** proximal Roux-en-Y gastric bypass

## Key facts

- **NCT ID:** NCT02514941
- **Lead sponsor:** University Medicine Greifswald
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-03
- **Final completion:** —
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02514941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02514941, "Bioavailability of Paracetamol, Amoxicillin and Talinolol Before, Immediately and One Year After Gastric Bypass Operation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02514941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*